USPTO serial 79326492
NERPHARMA PART OF NMS GROUP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 21, 2023
- Examiner
- PRIZANT, JAMES
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NERPHARMA PART OF NMS GROUP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey B. Sladkus, Esq.
Jeffrey B. Sladkus, Esq. The Sladkus Law Group1397 Carroll DriveAtlanta, GA 30318UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations for treating cancer, myocardium infarction and malaria; sanitary preparations for medical purposes; biological preparations for medical purposes, namely, for the treatment of cancer, myocardium infarction and malaria; chemical preparations for pharmaceutical purposes, namely, for treating cancer, myocardium infarction and malaria; chemico-pharmaceutical preparations for treating disease, namely, treating cancer, myocardium infarction and malaria; diagnostic preparations for medical purposes; pharmaceutical preparations for treating cancer, myocardium infarction and malaria | ACTIVE | — |
| 041 | Education, namely, providing classes, courses, seminars, workshops, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing of training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing entertainment in the nature of exhibitions, live shows, video and films, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; know-how transfer training related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; providing online electronic publications, not downloadable, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; publication of texts, other than publicity texts, related to research and development, testing, manufacturing and marketing in the genetic, medical and pharmaceutical field; arranging and conducting of conferences, congresses and symposium in the medical and pharmaceutical fields | ACTIVE | — |
| 042 | Scientific, technological, analysis and research services, namely, research and development in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; biological research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; chemical research in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; clinical trials in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; quality control in the field of medicine, testing in the field of pharmaceuticals and gene-based drugs and therapies; scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NERPHARMA S.R.L.
- Other trademarks owned by NERPHARMA S.R.L.
- Other trademarks owned by NERPHARMA S.R.L.
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named NERPHARMA PART OF NMS GROUP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 13, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 24, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 24, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 6, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 6, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 23, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 16, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 30, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 12, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 12, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 12, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 12, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 7, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 19, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 19, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 26, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |